抗 VEGF 贝伐单抗治疗 1 型 ROP 后极晚发性早产儿视网膜病变再激活：1 例报告。
Very late-onset reactivation of retinopathy of prematurity post anti-VEGF bevacizumab treatment for type 1 ROP: a case report.
机构信息
Texas A&M College of Medicine, College Station, Texas.
Ruiz Department of Ophthalmology and Visual Science, McGovern Medical School at The University of Texas Health Science Center, Houston, Texas, and Robert Cizik Eye Clinic, Houston, Texas.
出版信息
J AAPOS. 2021 Jun;25(3):180-184. doi: 10.1016/j.jaapos.2021.02.004. Epub 2021 May 6.
PMID:33964455
Abstract
We report the case of 10-year-old girl who developed retinal neovascularization and vitreous hemorrhage 10 years after successful treatment of type 1 retinopathy of prematurity infant with intravitreal bevacizumab without laser ablation therapy.
摘要
我们报告了一例 10 岁女孩的病例，她在成功接受玻璃体腔内贝伐单抗治疗 1 型早产儿视网膜病变后 10 年出现视网膜新生血管和玻璃体积血，而没有接受激光消融治疗。
Zotero 插件